RecruitingNCT07456397

Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential

Development and Validation of an Artificial Intelligence Platform for the Analysis of Sperm Samples and Prediction of Their Clinical Potential


Sponsor

Fecundis Lab SL

Enrollment

500 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to develop an artificial intelligence platform for the analysis of sperm samples and prediction of their clinical potential, in 500 semen samples, in an in vitro study over 24 months.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria4

  • Male participants:
  • Ability to provide a semen sample via masturbation
  • Semen sample intended for use in an IVF/ICSI cycle
  • Urdengoing an IVF/ICSI cycle with partner or donor semen

Exclusion Criteria7

  • Current diagnosis of a sexually transmitted infection (STI)
  • Previous diagnosis of hepatitis A, B, C, D, or HIV
  • Prior participation in this study
  • Participation in a clinical trial involving an intervention within the last 3 months
  • Female participants:
  • Prior participation in this study
  • Participation in a clinical trial involving an intervention within the last 3 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESwim-up

Sperm samples will be processed by swim-up technique

DEVICEDensity gradient centrifugation

Sperm samples will be processed by density gradient centrifugation

DEVICEHyperSperm

Sperm samples will be processed by HyperSperm


Locations(5)

Eugin Barcelona

Barcelona, Barcelona, Spain

Fertty

Barcelona, Barcelona, Spain

CIRH

Barcelona, Barcelona, Spain

Fertilab Barcelona

Barcelona, Barcelona, Spain

Natuvitro

Barcelona, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07456397


Related Trials